Tvardi Therapeutics, Inc. (FRA:69C)
Germany · Delayed Price · Currency is EUR 3.030
+0.310 (11.40%)
At close: Jan 9, 2026
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of €36.7 million as of January 9, 2026.
Market Cap
36.70M
Enterprise Value
5.55M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.03
Market Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from 150.27M to 36.70M, a decrease of -75.58%. That is a compound annual growth rate of -85.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 36.70M | 6.81% |
| Dec 31, 2025 | 34.36M | -77.14% |
| Apr 16, 2025 | 150.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |